z-logo
open-access-imgOpen Access
Continuous Intravenous Infusion of Bumetanide to Achieve Diuresis in Patients with Congestive Heart Failure and Chronic Kidney Disease: A Rapid Review
Author(s) -
Deepak Goyal
Publication year - 2021
Publication title -
hsoa journal of nephrology and renal therapy
Language(s) - English
Resource type - Journals
ISSN - 2473-7313
DOI - 10.24966/nrt-7313/100045
Subject(s) - bumetanide , furosemide , diuresis , heart failure , medicine , loop diuretic , diuretic , kidney disease , intensive care medicine , anesthesia , cardiology , kidney , cotransporter , chemistry , organic chemistry , sodium
Bumetanide falls in the class of loop diuretics like furosemide. The effects of both have been extensively researched and are well documented. In medical practice furosemide is more widely used in patients both orally and through intravenous administration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here